Next Thursday, March 28, Professor José Manuel Sánchez-Vizcaíno will participate in the Scientific Congress on African Swine Fever that will take place at the National Institute of Animal Health in Bangkok, Thailand.
Professor Sánchez-Vizcaíno travels to Beijing next Tuesday 26th, to participate in this international congress with the conferences entitled:
"Global situation of ASF" and "Control and eradication of ASF in different epidemiological scenarios".
The National Association of Veterinarians of Iberian Pig organizes the 11th ANVEPI Forum on the 13th and 14th of March at the Casa Colón Complex Conference Center.
During the day, Professor Sánchez-Vizcaíno will participate in the round table entitled "Control tools in the African Swine Fever" along with Fernando Rodríguez González and Pedro José Sánchez-Cordón.
New research article pusblished in BMC Veterinary Research journal.
The Center for Animal Health and Food Safety of the University of Minnesota organized this interview about African Swine Fever with Professor José Manuel Sánchez Vizcaíno.
Episode 3 features Dr. Jose Manuel Sanchez Vizcaino, full professor at the Universidad Complutense Madrid and director of the OIE reference laboratory for African Swine Fever, and Dr. Tom Molitor, chair of the Department of Veterinary Population Medicine at the College of Veterinary
Professor José Manuel Sánchez-Vizcaíno participated this year in the SEPOR symposium where was awarded with the Gold SEPOR to the Research. and where announced the creation of the first vaccine against African Swine Fever.
This new was published in several media:
Professor José Manuel Sánchez-Vizcaíno attended the International "PIC Symposium" at Pudong, in Shanghai, the dates November 1-2, 2018.
He participated as invited speaker giving the talk: "Biosecurity and Control of ASF in Different Scenarios".
The magazine Animal's Health in the article "Spanish researchers, near the vaccine against African Swine Fever" writes about Professor José Manuel Sánchez Vizcaíno advances on the prototype of the African Swine Fever vaccine in which they are currently working.